{"id":47339,"date":"2024-10-28T10:29:11","date_gmt":"2024-10-28T09:29:11","guid":{"rendered":"https:\/\/capitalmind.com\/?post_type=deals&#038;p=47339"},"modified":"2024-11-04T14:28:54","modified_gmt":"2024-11-04T13:28:54","slug":"cession-dintiquan-a-productlife-group","status":"publish","type":"deals","link":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/","title":{"rendered":"Cession d&rsquo;IntiQuan \u00e0 ProductLife Group"},"content":{"rendered":"\n<p><strong>Investec conseille les actionnaires d\u2019IntiQuan \u00e0 l\u2019occasion de la cession de la soci\u00e9t\u00e9 \u00e0 ProductLife Group (PLG)<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-a-propos-du-deal\">A propos du deal<\/h2>\n\n\n\n<p>PLG est un leader mondial dans le conseil en services de transformation digitale, r\u00e9glementaire, scientifique et de conformit\u00e9 pour l\u2019industrie des sciences de la vie, soutenu par les fonds d&rsquo;investissement Oakley Capital et 21 Invest.<\/p>\n\n\n\n<p>Fond\u00e9 en Suisse en 2015 par le Dr Henning Schmidt, IntiQuan s\u2019est rapidement impos\u00e9 comme un partenaire de confiance du secteur de la biopharma offrant des services &amp; solutions pour le d\u00e9veloppement de m\u00e9dicaments (services de mod\u00e9lisation et de simulation pharmacom\u00e9triques et statistiques).<\/p>\n\n\n\n<p>Cette acquisition permet \u00e0 PLG d&rsquo;enrichir son portefeuille de solutions sp\u00e9cialis\u00e9es pour soutenir les entreprises biopharmaceutiques dans le d\u00e9veloppement de m\u00e9dicaments, en ajoutant un ensemble cl\u00e9 de comp\u00e9tences visant \u00e0 r\u00e9duire consid\u00e9rablement les risques, les co\u00fbts et les d\u00e9lais de d\u00e9veloppement, tout en renfor\u00e7ant la s\u00e9curit\u00e9 des patients gr\u00e2ce \u00e0 des analyses dose-r\u00e9ponse avanc\u00e9es et des profils de s\u00e9curit\u00e9 pr\u00e9dictifs. En r\u00e9alisant l\u2019acquisition d\u2019IntiQuan, PLG est d\u00e9sormais en mesure d&rsquo;offrir \u00e0 ses clients des services pharmacom\u00e9triques de pointe incluant du conseil strat\u00e9gique, des services de pharmacocin\u00e9tique\/pharmacodynamie (PK\/PD), de pharmacocin\u00e9tique de population (popPK) et de biosimulation. IntiQuan est reconnu pour sa capacit\u00e9 \u00e0 transformer des donn\u00e9es complexes en informations exploitables dans un large \u00e9ventail de domaines th\u00e9rapeutiques et de modalit\u00e9s, de la phase pr\u00e9clinique \u00e0 la phase IV. Son \u00e9quipe d\u2019experts scientifiques s\u2019appuie sur des techniques avanc\u00e9es de mod\u00e9lisation math\u00e9matique et de simulation pour orienter la conception des \u00e9tudes cliniques, ainsi que pour analyser et pr\u00e9dire les r\u00e9sultats des essais. <\/p>\n\n\n\n<p>Cette acquisition repr\u00e9sente une \u00e9tape suppl\u00e9mentaire dans la strat\u00e9gie de PLG visant \u00e0 cr\u00e9er une plateforme mondiale pleinement int\u00e9gr\u00e9e. Avec d&rsquo;autres expansions pr\u00e9vues aux \u00c9tats-Unis et en Europe, PLG est en bonne voie pour devenir un leader mondial dans la fourniture de services complets de d\u00e9veloppement de m\u00e9dicaments.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-notre-role\">Notre r\u00f4le<\/h2>\n\n\n\n<p>L\u2019\u00e9quipe Investec a conseill\u00e9 les actionnaires d\u2019IntiQuan tout au long du processus de cession&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pr\u00e9paration de la documentation marketing (<em>equity story, business plan<\/em>)<\/li>\n\n\n\n<li>Identification des acqu\u00e9reurs (strat\u00e9giques &amp; financiers) potentiels les plus pertinents<\/li>\n\n\n\n<li>Mise en \u0153uvre et animation du processus de vente comp\u00e9titif<\/li>\n\n\n\n<li>Organisation &amp; animation de la phase de due diligence<\/li>\n\n\n\n<li>Assistance \u00e0 la n\u00e9gociation du deal <\/li>\n<\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00ab\u00a0Le rapprochement avec PLG est un moment charni\u00e8re pour IntiQuan, offrant de nombreux leviers pour la poursuite du succ\u00e8s de notre entreprise. Investec a jou\u00e9 un r\u00f4le cl\u00e9 dans la r\u00e9alisation de cette op\u00e9ration. Sa pr\u00e9sence \u00e0 l\u2019international, sa connaissance approfondie du secteur et son engagement fort ont \u00e9t\u00e9 d\u00e9terminants pour faire face aux complexit\u00e9s rencontr\u00e9es au cours du processus et aboutir \u00e0 une transaction avec un partenaire actif \u00e0 l\u2019\u00e9chelle mondiale et pr\u00e9sentant une forte ad\u00e9quation strat\u00e9gique et culturelle avec IntiQuan. Nous sommes ravis de l\u2019accompagnement dont nous avons b\u00e9n\u00e9fici\u00e9 \u00e0 l\u2019occasion de ce processus \u00e0 tr\u00e8s fort enjeu pour nous.\u201c<\/em><\/p>\n<cite><em><strong>Dr. Henning Schmidt<\/strong>, foundateur d&rsquo;IntiQuan AG<\/em><\/cite><\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Investec conseille les actionnaires d\u2019IntiQuan \u00e0 l\u2019occasion de la cession de la soci\u00e9t\u00e9 \u00e0 ProductLife Group (PLG) A propos du&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3705,3768],"dealtype":[3706],"clienttype":[3729],"class_list":["post-47339","deals","type-deals","status-publish","hentry","sector-business-services-fr","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.10 (Yoast SEO v26.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cession d&#039;IntiQuan \u00e0 ProductLife Group | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec Business Advisory Cession d&#039;IntiQuan \u00e0 ProductLife Group\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession d&#039;IntiQuan \u00e0 ProductLife Group\" \/>\n<meta property=\"og:description\" content=\"Investec Business Advisory Cession d&#039;IntiQuan \u00e0 ProductLife Group\" \/>\n<meta property=\"og:url\" content=\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T13:28:54+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/\",\"name\":\"Cession d'IntiQuan \u00e0 ProductLife Group | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\"},\"datePublished\":\"2024-10-28T09:29:11+00:00\",\"dateModified\":\"2024-11-04T13:28:54+00:00\",\"description\":\"Investec Business Advisory Cession d'IntiQuan \u00e0 ProductLife Group\",\"breadcrumb\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/working.capitalmind.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession d&#8217;IntiQuan \u00e0 ProductLife Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory\",\"https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cession d'IntiQuan \u00e0 ProductLife Group | Investec Business Advisory","description":"Investec Business Advisory Cession d'IntiQuan \u00e0 ProductLife Group","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Cession d'IntiQuan \u00e0 ProductLife Group","og_description":"Investec Business Advisory Cession d'IntiQuan \u00e0 ProductLife Group","og_url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/","og_site_name":"Investec Business Advisory","article_modified_time":"2024-11-04T13:28:54+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/","url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/","name":"Cession d'IntiQuan \u00e0 ProductLife Group | Investec Business Advisory","isPartOf":{"@id":"https:\/\/working.capitalmind.com\/fr\/#website"},"datePublished":"2024-10-28T09:29:11+00:00","dateModified":"2024-11-04T13:28:54+00:00","description":"Investec Business Advisory Cession d'IntiQuan \u00e0 ProductLife Group","breadcrumb":{"@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dintiquan-a-productlife-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/working.capitalmind.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession d&#8217;IntiQuan \u00e0 ProductLife Group"}]},{"@type":"WebSite","@id":"https:\/\/working.capitalmind.com\/fr\/#website","url":"https:\/\/working.capitalmind.com\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/working.capitalmind.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/working.capitalmind.com\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/working.capitalmind.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/47339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=47339"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=47339"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=47339"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=47339"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=47339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}